LEO Pharma Announces Topline Results of Phase 3 Trial in China for Enstilar® (LEO 90100) Demonstrating Superiority in Adult Chinese Subjects With Stable Plaque Psoriasis
Enstilar® (LEO 90100) showed superiority over Daivobet® ointment in primary and both secondary endpoints in the testing hierarchy showing improved efficacy in... Read more.
IDEX Corporation Declares Regular Quarterly Cash Dividend
NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend... Read more.
IDEX Corporation Declares Regular Quarterly Cash Dividend
NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend... Read more.
MENA Region Leads Global Growth in Luxury Travel, Reveals Mastercard Affluent Travel Report
Report highlights the role of high-net-worth travelers in boosting the travel and hospitality industry Over a third (38%) of luxury seekers are willing to pay... Read more.
T-Mobile to Offer New iPad Pro and iPad Air
BELLEVUE, Wash.–(BUSINESS WIRE)–T-Mobile (NASDAQ: TMUS) will offer the new iPad Pro in a stunning, thin and light design, with a breakthrough Ultra Retina... Read more.
NEW Logitech Combo Touch Available for the new iPad Air and iPad Pro
Elevate the iPad experience with this versatile keyboard case featuring a large trackpad and slim design LAUSANNE, Switzerland & SAN JOSE, Calif.–(BUSINESS... Read more.
MITRE to Establish New AI Experimentation and Prototyping Capability for U.S. Government Agencies
MITRE Federal AI Sandbox to be Powered by NVIDIA DGX SuperPOD MCLEAN, Va.–(BUSINESS WIRE)–MITRE is building a new capability intended to give its artificial... Read more.
Klick Health Wraps First Round of $1,000,000 Klick AI Prize, Awarding First $200,000 to Three Teams
Winning entries selected by judging panel of executives from Boehringer Ingelheim, Bristol Myers Squibb, Lily, Novartis, Otsuka, Pfizer, Sanofi, and other leading... Read more.
MiDROPS® Achieves Pivotal Milestone: Proven Safe and Effective in Phase II Clinical Trial
OKLAHOMA CITY–(BUSINESS WIRE)–EyeCRO is thrilled to announce that groundbreaking data from the first clinical application of its innovative MiDROPS®... Read more.
USIC Announces Partnership With the U.S. Army Reserve’s P3O (Private Public Partnership) Program
INDIANAPOLIS–(BUSINESS WIRE)–USIC, LLC (“USIC”), the leader in underground utility damage prevention, signed a proclamation of partnership with the... Read more.